2022-2023 | Frank Roushar, PhD | Research Scientist, Remedy Plan Therapeutics, Rockville, Maryland |
2019-2021 | Swetha Parvathaneni, PhD | Post-doctoral Fellow, Food and Drug Administration, Rockville, Maryland |
2016-2020 | Laetitia Gorisse, PhD | Project Coordinator, Medpace, Lyon, France |
2015-2017 | Samar Sayedyahossien, MD, PhD | Research Associate, Department of Anatomy and Cell Biology, Western University, London, Ontario, Canada |
2014-2020 | Andrew Hedman, PhD | Scientist, M6P Therapeutics, St Louis, Missouri |
2013-2015 | Jessica M. Smith, PhD | Health Specialist, Office of Strategic Coordination, NIH, Bethesda, Maryland |
2012-2014 | Bhavna Chawla, PhD | Research Associate, University of Maryland School of Medicine |
2010-2013 | Halil H. Erdemir, MD | Fellow, Pediatric Hematology/Oncology, Cleveland Clinic, Cleveland, Ohio |
2009-2010 | Hugh Kim, DMD, PhD | Aaaociate Professor, University of British Columbia, Vancouver, Canada |
2008-2010 | Colin D. White, PhD | Chief Scientific Officer, Parcell Laboratories, Waltham, Massachusetts |
2006-2007 | Anders Berg, MD, PhD | Associate Professor of Pathology, Cedars-Sinai, Los Angeles, California |
2005-2008 | Matthew D. Brown, PhD | Bioscience Application Manager (N. America) at Malvern PANalytical, Westborough, Massachusetts |
2005-2007 | Ha-Won Jeong, MD, PhD | Research Fellow, Harvard Medical School |
2004-2007 | Jian-Guo Ren, PhD | Principal Scientist, Aileron Therapeutics, Cambridge, MA |
2004-2005 | Maria Psatha, PhD | Study manager, UCL Hospitals, Biomedical Research Centre, London, UK |
2003-2006 | Monideepa Roy, PhD | Founder/VP of Product Development, Akamara Therapeutics Inc, Cambridge, Massachusetts |
2003-2005 | Misty Ward, PhD | Chief Operating Officer, InterveXion Therapeutics, LLC, Little Rock, Arkansas |
2003-2007 | Lorraine Jadeski, PhD | Associate Professor, University of Guelph, Guelph, Ontario, Canada |
2001-2006 | Lu Li, MD, PhD | Principal Scientist, EMD Serono, Inc., Billerica, Massachusetts |
2000-2003 | Jennifer Mataraza, PhD | Director and Head, Translational Immuno Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts |
2000-2003 | Michael Briggs, PhD | Product Line Manager, Drug Discovery, Corning Life Sciences, Kennebunk, Maine |
1993-1997 | John Joyal, PhD | Chief Operating Officer Research, Moderna, Cambridge, Massachusetts |
1992-1993 | Milenko Tanasijevic, MD | Associate Professor of Pathology, Harvard Medical School |